Ercros S A : participates in a conference on the rational use of antibiotics
May 28, 2024 at 04:10 pm
Share
María Luisa Díez Escanciano, head of R&D of the pharmaceuticals division of Ercros, participated in the Conference on the rational use of antibiotics with the presentation "Antibiotic production, a long road to commercialization".
At this conference, organized by the Tajo University Hospital, the perspectives of the National Plan against antibiotic resistance, which seeks to rationalize the use of these medications, were discussed. The Plan was launched in 2014 by the Spanish government, together with scientific societies, collegiate organizations, professional associations and universities.
In addition to María Luisa Díez, specialists in the use of antibiotics participated in the conference, such as the heads of the pharmaceutical and paediatric services of the Hospital del Tajo, and the head of the microbiological laboratory service of the Ramon y Cajal Hospital in Madrid, who gave presentations on the final destination of antibiotics, bacterial resistance or the environmental footprint.
Ercros produces generic active pharmaceutical ingredients (API), mainly in the field of antibiotics, in its Aranjuez factory, a production centre that will celebrate its 75th anniversary in 2024.
Attachments
Original Link
Permalink
Disclaimer
Ercros SA published this content on
28 May 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
28 May 2024 15:09:35 UTC.
Ercros SA is a Spain-based company engaged, together with its subsidiaries, in the chemical industry. The Companyâs products are structured into three business lines: Businesses Associated to Chlorine, which comprises the production of chlorine, ethyl acetate, caustic soda, sodium hypochlorite, dichloroethane, chloromethane, sodium chlorate and caustic potash, polyvinyl chloride (PCV), as well as water disinfectants; Intermediate Chemicals, which produces formaldehyde, glues and resins for the fiberboard and plywood industries, and Pharmaceuticals, which comprises raw material and intermediate products used in the pharmaceutical industry. The Company owns such subsidiaries as Marcoating SLU, Gades Ltd and Ercekol AIE, among others. In April 2014, it sold Fosfatos de Cartagena SLU to Timab Iberica.